- Home
- LESL vs KROS Comparison
LESL vs KROS Comparison
Compare LESL & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LESL
- KROS
- Stock Information
- Founded
- LESL 1963
- KROS 2015
- Country
- LESL United States
- KROS United States
- Employees
- LESL N/A
- KROS N/A
- Industry
- LESL Diversified Commercial Services
- KROS Biotechnology: Pharmaceutical Preparations
- Sector
- LESL Miscellaneous
- KROS Health Care
- Exchange
- LESL Nasdaq
- KROS Nasdaq
- Market Cap
- LESL 538.1M
- KROS 589.8M
- IPO Year
- LESL 2020
- KROS 2020
- Fundamental
- Price
- LESL $2.16
- KROS $10.86
- Analyst Decision
- LESL Hold
- KROS Buy
- Analyst Count
- LESL 8
- KROS 11
- Target Price
- LESL $3.96
- KROS $45.33
- AVG Volume (30 Days)
- LESL 5.2M
- KROS 2.0M
- Earning Date
- LESL 01-30-2025
- KROS 02-26-2025
- Dividend Yield
- LESL N/A
- KROS N/A
- EPS Growth
- LESL N/A
- KROS N/A
- EPS
- LESL N/A
- KROS N/A
- Revenue
- LESL $1,330,121,000.00
- KROS $651,000.00
- Revenue This Year
- LESL $4.50
- KROS $303.39
- Revenue Next Year
- LESL $4.10
- KROS N/A
- P/E Ratio
- LESL N/A
- KROS N/A
- Revenue Growth
- LESL N/A
- KROS 8037.50
- 52 Week Low
- LESL $2.02
- KROS $9.78
- 52 Week High
- LESL $8.21
- KROS $73.00
- Technical
- Relative Strength Index (RSI)
- LESL 42.21
- KROS 20.25
- Support Level
- LESL $2.14
- KROS $9.78
- Resistance Level
- LESL $2.36
- KROS $16.49
- Average True Range (ATR)
- LESL 0.13
- KROS 0.92
- MACD
- LESL 0.02
- KROS 0.97
- Stochastic Oscillator
- LESL 26.03
- KROS 14.52
About LESL Leslie's Inc.
Leslies Inc is a direct-to-consumer pool and spa care brand offering a comprehensive assortment of products across chemicals, equipment and parts, cleaning and maintenance equipment, and safety, recreational, and fitness-related products. The company offers its products and services for Residential Pool, Residential Spa, Professional Pool, and Commercial Pool consumers. Geographically, it operates only in the United States.
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.